Back to search
ALK-Positive Anaplastic Large Cell Lymphoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which ALK-Positive Anaplastic Large Cell Lymphoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which ALK-Positive Anaplastic Large Cell Lymphoma trials you may qualify forThis study involves patients with diffuse large B cell lymphoma (DLBCL), natural killer/T-cell lymphoma (NKTL), or classical Hodgkin lymphoma (cHL) (referred to…
The researchers are doing this study to see if alectinib in combination with duvelisib is a safe and effective time-limited treatment for people with relapsed o…
This is a multicenter, randomized, double-blind, placebo-controlled phase III trial evaluating golidocitinib as maintenance therapy in adult patients with perip…
This is an open-label, phase I-II dose-escalation and expansion study designed to define the recommended dose of brigatinib as monotherapy in pediatric and youn…
This clinical trial is looking at a drug called alectinib. Alectinib is approved as standard of care treatment for adult patients with certain types of lung can…
The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the inform…
This randomized, active-controlled, multicenter, open-label, Phase III study is designed to investigate the efficacy and safety of alectinib compared with plati…
The purpose of this study is to test the safety, tolerability, efficacy, and drug levels of BMS-986369 (Golcadomide) in participants with relapsed or refractory…